cystic fibrosis Flashcards

1
Q

what is cystic fibrosis?

A

A genetic autosomal recessive, systemic and multiorgan disease caused by defective ion transport

The most common lethal genetic autosomal recessive disease in the white population

Imbalance of fluid and electrolytes causing thick, sticky mucus and viscous secretions to accumulate in different organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which population is CF more common in?

A

caucasian population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the life expectancy of CF

A

mid 40s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does autosomal and recessive mean?

A

Autosomal: Refers to any of the chromosomes other than the sex-determining chromosomes

Recessive: not expressed unless both copies are present i.e., two copies of the mutation are needed to cause the disease.

Autosomal Dominant: A gene on one of the non-sex chromosomes that is always expressed, even if only one copy is present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is cystic fibrosis caused by?

A

Cystic fibrosis is caused by a mutation in a gene that encodes Cystic Fibrosis Transmembrane conductance Regulator: a chloride channel expressed in epithelial cells and other type of cells

CFTR is located in the apical membrane of secretory and absorptive epithelial cells of the pancreas, intestine, liver, airway, vas deferens and sweat glands

CFTR protein functions as a cyclic AMP-dependent chloride channel, a bicarbonate channel and as a modulator of other ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is CFTR ?
Conductance Regulator Protein Channel
and its structure

A

CFTR is a chloride channel expressed in epithelial cells and other type of cells that maintains salt, fluid, and pH homeostasis in various epithelial tissues

TWOCFTRmolecules line up in parallel, tail by tail, forming a pore in its center.

NBD (nucelotide binding domain) and RD (regulatory domain) are in the cytosol and the MD (membrane domain) form the pore of the channel. Both RD and NBD are involved in regulating the channel activity. RD is phosphorylated by a cAMP-dep kinase, NBDs bind to and hydrolase ATP providing energy to open and close the pore. Major function is regulating chloride conductance but CFTR plays other roles including regulation of sodium absorption

CFTRmutations can occur in the gene sequence that encodes any of the 5 protein domains. However, many mutations occur in the sequence that encodes NBD1, including theF508delmutation.
The location of theCFTRmutations can affect the formation or function of the CFTR protein.2

CFTR is a protein that is found in various cell types, including lung epithelium, submucosal glands, pancreas, liver, sweat ducts and reproductive tract
CFTR is located in the apical membrane of secretory and absorptive epithelial cells of the pancreas, intestine, liver, airway, vas deferens and sweat glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is CFTR ?
Conductance Regulator Protein Channel
and its structure
skip

A

CFTR is a chloride channel expressed in epithelial cells and other type of cells that maintains salt, fluid, and pH homeostasis in various epithelial tissues

TWOCFTRmolecules line up in parallel, tail by tail, forming a pore in its center.

NBD (nucelotide binding domain) and RD (regulatory domain) are in the cytosol and the MD (membrane domain) form the pore of the channel. Both RD and NBD are involved in regulating the channel activity. RD is phosphorylated by a cAMP-dep kinase, NBDs bind to and hydrolase ATP providing energy to open and close the pore. Major function is regulating chloride conductance but CFTR plays other roles including regulation of sodium absorption

CFTRmutations can occur in the gene sequence that encodes any of the 5 protein domains. However, many mutations occur in the sequence that encodes NBD1, including theF508delmutation.
The location of theCFTRmutations can affect the formation or function of the CFTR protein.2

CFTR is a protein that is found in various cell types, including lung epithelium, submucosal glands, pancreas, liver, sweat ducts and reproductive tract
CFTR is located in the apical membrane of secretory and absorptive epithelial cells of the pancreas, intestine, liver, airway, vas deferens and sweat glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

where is CFTR found and its role there:

A

Pancreas: It maintains a normal volume and pH of pancreatic secretions necessary for digestion of nutrients

Lungs. It regulates salt and water balance, thus contributes to normal hydration of airways mucociliary clearance

GI-tract. It regulates the balance of electrolytes and fluid thus GI normal hydration, appropriate pH and normal composition of intestinal secretions

CFTR is a protein that is found in various cell types, including lung epithelium, submucosal glands, pancreas, liver, sweat ducts and reproductive tract
CFTR is located in the apical membrane of secretory and absorptive epithelial cells of the pancreas, intestine, liver, airway, vas deferens and sweat glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what can CF cause?

A
pulmonary disease 
pancreatic dysfunction 
infertility 
salty skin 
gastrointestinal symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is pulmonary disease?

clinical manifestation

A
Copious sputum production
Persistent cough 
Reduced lung function
Inflammation and tissue damage
Chronic Airway Infections
Predominant organisms H. influenzae
S. aureus
P. aeruginosa

Chronic lung disease is the dominating manifestation and main cause of morbidity and mortality for CF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is pancreatic dysfunction?

2 types

A

Exocrine pancreatic insufficiency
Impaired enzyme secretion from pancreas and malnutrition

Endocrine pancreatic insufficiency
CF related diabetes mellitus (30% of patients over 25)

In CF, pancreatic secretions have lower fluid volumes and increased acidity within the pancreatic lumen which leads to precipitation of the protein rich secretions, causing plugging of small ducts, obstruction, and progressive damage to the pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

other clinical manifestation of CF?

A

Meconium ileus: 20% of babies with CF; however, meconium ileus can have other reasons than CF

Gastrointestinal Symptoms: thickened intestinal secretion, malabsorption, malnutrition, decreased gut motility

Salty-tasting skin

Infertility: congenital absence of the vas deferens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what can mutations do?

A

Reduce transcription OR translation
Affect traffinking to surface
Accelerate protein turnover
Cause loss of protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

F508del class II mutation and CF

A

Thick, sticky mucous buildup flattens cilia

CFTR protein is made but cannot reach the cell surface. The mutant needs a corrector and a potentiator.

When a mutation causes an amino acid to be deleted or an incorrect amino acid to be added, the CFTR protein cannot form its correct 3-D shape and function properly. These mutations are considered to be protein processing mutations.

The most common CF mutation, F508del, is primarily considered to be a missense amino acid deletion and a Protein Processing Mutation. The F508del mutation removes a single amino acid from the CFTR protein. Without this, the CFTR protein cannot stay in the correct 3-D shape. The cell recognizes that the protein isn’t the right shape and disposes of it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

G551D class III mutation and CF

A

Thick, sticky mucous buildup flattens cilia

CFTR protein can reach the cell surface but is defective: channel opening and gating are compromised (doorman problem).

G551D glycine to aspartate is a ‘missense’ amino acid change mutation that results in defective channel gating.
A change in one of the amino acids of CFTR means that even though the protein makes the right 3-D shape, it doesn’t function as well as it should.
This type of gating mutation locks the gate in the closed position so that chloride cannot get through. The G551D mutation abolishes ATP-dependent gating, resulting in an open probability that is approximately 100-fold lower than that of wild-type channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the test for cystic fibrosis?

A

Blood test in new-born testing for the most common gene alterations that cause CF

Sweat test in a child/adult with clinical features of the disease.
In CF sweat has higher levels of salt than normal

In the lung.
In epithelial cells, a dysfunction of the Cl channel affects the outflow (exit) of Cl . That, together with the fact that also reabsorption of Na is impaired will affect the quantity of H2O on the surface of the epithelial cells. In patient with CF you have thickening of the mucus and malfunctioning of cilia.

17
Q

how does a sweat test work?

A

A sweat test measures the amount of salt in sweat. It is usually done by applying a very weak and painless electric current to a small area of skin to which a harmless chemical has been applied. This causes that area of skin to sweat. A sample of the sweat is then collected and analysed. If the salt content in the sweat is abnormally high, this confirms cystic fibrosis.

In the sweat gland.
In normal sweat glands, in the dermis, chloride is absorbed out of the sweat in a CFTR-dependent manner (i.e., via the Cl channel when the sweat travels from the gland to the skin surface). In patients with CF, dysfunctional Cl channels will prevent chloride absorption thus the sweat that reaches the skin surface has higher than normal chloride concentrations (salty sweat)

18
Q

what is cystic fibrosis pathogenesis?

A

1) CFTR gene defect
2) defective ion transport
- reduce chloride transport
- increase sodium absorption
- increase h20 absorption
3) airway surface liquid depletion
4) defective mucocilliary clearance
5) mucus obstruction
6) infection
7) inflammation (leads back to mucus obstruction)

The CFTR are transmembrane ion channels that move sodium and chloride across cell membranes - water follows the flow of chloride ions to the cell surface, which consequently helps to hydrate the surface of the cell and thin the secretions (i.e. mucous) around the cell.

Mutations in the CFTR gene produce CFTR proteins of insufficient quantity and/or function, leading to defective ion transport (mainly decrease of chloride, enhanced sodium absorption through epithelial Na+ channels (ENaC) and basolateral Na/K ATPase pumps). This affects the movement of water in and out of the tissues and impacts the production of mucus that lubricates and protects certain organs and body tissues or the secretions. A build-up of thick mucous throughout the body causes multi-organ disease In the lung, defective ion transport leads to a net increase in water absorption

Thus a reduction of airway surface liquid, build-up of thick mucous

impaired ciliary clearance

mucus obstruction

infection and inflammation.

19
Q

what are the management options for each stage of cystic fibrosis?

A

1) CFTR gene defect
2) defective ion transport
3) airway surface liquid depletion - POTENTIATOR and CORRECTOR
4) defective mucocilliary clearance
5) mucus obstruction - MUCOACTIVE and PYSIOTHERAPY
6) infection - IMMUNOMODULATORY THERAPY and ANTIMICROBALS
7) inflammation (leads back to mucus obstruction)

20
Q

what is the role of mucoactives?

A

Increase the ability to expectorate sputum and/or decrease mucus hypersecretion

Can be classified as expectorants, mucoregulators, mucolytics or mucokinetics, based on their potential mechanism of action.

expectorants (induce cough or increase the volume of secretions)
mucolytics (reduce the viscosity of mucus)
mucokinetic drugs (increase the mobility and transportability of mucus)
and mucoregulators (control the process of hypersecretion)

21
Q

what is examples of mucoactives?

and its role

A

(first line)
Inhaled recombinant human DNase I -rhDNase (Dornase alfa, Pulmozyme®):
Peptide mucolytic: degrades the large amount of polymerised DNA and F-actin network that accumulates within CF mucus
Reduces viscosity of bronchial secretion. Improving the viscoelastic properties of airway secretions promotes airway clearance. Nebulised.

Hypertonic saline (7%): 
Expectorant: draws water into the airways
Causes osmotic hydration of the periciliary layer and allows improved mucociliary clearance.Nebulised.

Mannitol (Bronchitol®, Pharmaxis®):
Osmotic agent: creates a luminal osmotic gradient, drawing water into the airway lumen. Other mechanism?
Improves hydration of airway secretions and reduces sputum viscosity to increase mucociliary clearance.Inhaled.
Mannitol not actively transported and poorly absorbed after inhalation

22
Q

what are example CFTR potentiator?

and its use?

A
Ivacaftor (Kalydeco®)
Channel potentiator (conductance regulator): by increasing the open-channel probability, it facilitates chloride transport. 
Use: specific for the treatment of patients with at least one copy of G551D  ‘missense’ mutation or rarer mutationsthat results in defective channel gating. Oral.
23
Q

what is lumacafator and its use?

A

Lumacaftor

Channel corrector: acts as a protein-folding chaperone, aiding the conformational stability of the mutated CFTR protein.
↑processing and trafficking of mature protein to the cell surface.

Use: specific for the treatment of CF in patients homozygous for delta-F508 mutations. Oral.
Available withIvacaftoras the fixed dose combination (Orkambi®)
Not recommended in UK (2017 guideline) but available on the NHS (Nov2019)

24
Q

what is tezacaftor

and its use?

A

Tezacaftor
A channel corrector: aims to repair CFTR cellular misprocessing by modulating the position of the CFTR protein on the cell surface to the correct position

Use: for patients homozygous or heterozygous for the F508del mutation or with rarer mutations.
In UK available on the NHS with ivacaftor (Symkevi®)

25
Q

what is Elexacaftor and its use

A

Elexacaftor

A channel corrector: modulates CFTR proteins to facilitate trafficking to the cell surface for incorporation into the cell membrane

Use: designed for patients who are heterozygous forF508del-CFTR, for a gene that does not produce protein or for a gene that produces proteins unresponsive to ivacaftor or tezacaftor (correctors)

26
Q

what is triple combination therapy for CF?

A

Elexacaftor with ivacaftor and tezacaftor (Kaftrio®) available on the NHS for patients homozygous for the F508del mutation or heterozygous for F508del with a minimal function mutation.

27
Q

what are the examples of CFTR corrector?

A

lumacafator
tezacafator
elexacaftor

28
Q

what are non-pharmacological treatment for CF?

A

chest physiotherapy
To augment clearance of tenacious airway secretions

1) Postural Drainage
Person gets in varied positions that help draining mucus

2) Percussion
Chest is clapped and vibrated to help dislodge mucus to large airways

Chest physiotherapy is gently “clapping” parts of the body to remove mucus from the lungs. They are often used together in conditions such as cystic fibrosis

3) Use mucolytics and b-agonists before physiotherapy

4) Airway-oscillating devices, high-frequency chest wall oscillation devices
Person wears vibrating vest

5) Active Cycle of Breathing Technique

29
Q

what is immunomodulatory therapy and use

A

To provide immunomodulatory and anti- inflammatory effects

Immunomodulatory= A dose of a drug that is less than the minimum inhibitory dose.

Azithromycin
Broad-spectrum macrolide antibiotic

Use: long-term treatment at immunomodulatory dose for patient with CF and deteriorating lung function or repeatedpulmonary exacerbations.
250−500mg 3times weekly/ 6 months (Cystic Fibrosis Trust guideline).
Note: Possible development of antibiotic resistance! 

30
Q

what are examples of antimicrobials and its use?

A

Flucloxacillin
Antibiotic prophylaxis
Use: Children with CF from diagnosis up to age 3 (consider continuing up to 6 years of age!)

Other antibiotics:
Eradication treatment 
Appropriate antibiotics (according to diagnosis)
Oral 
 i.v. 
Combination
31
Q

what are the management of other clinical manifestations ?

A

Increase calorie intake
Increased portion size and eat high-caloric food

Consider oral nutritional supplements
Fat-soluble-vitamin supplementation

Pancreatic enzymes replacement therapy
To ensure proper digestion

Regular exercise
To improve both lung function and overall fitness.

32
Q

what are counselling advices for CF

A
  • inhalers- standard inhaler technique
  • mucoactives - use drugs regularly and before physiotherapy
  • CFTR potentiator and corrector - use regularly, taken with fat containing food to promote absorption of these drugs, should not be taken with grapefruit
  • antibiotics - same time of the day ,complete full course, taken with food or without food?
33
Q

summary:

treatment:
- increase CAL and protein
- pulmonary therapy - postural drainage
- breathing exercises
- aerosol therapy

meds:

  • antibiotic
  • supplemental vitamins
  • aerosols - bronchodialtors
  • mucolytics
  • pancreatic enzymes

symptoms

  • fatigue
  • chronic cough
  • recurrent URIs
  • Thick,sticky mucus
  • chronic hypoxia: clubbing, barrel chest
  • decrease in absorption of vitamins and enzymes

diagnoses :
-salty taste on skin

A